Management of Viral Exanthems in Children

Initial Assessment

Evaluate the severity of the exanthem and associated symptoms, including presence of fever, respiratory distress, altered mental status, or signs of dehydration, as recommended by Thorax 1
Assess for signs of respiratory involvement such as increased respiratory rate, grunting, intercostal recession, or breathlessness with chest signs, which may indicate more severe disease requiring hospital admission, according to Thorax 1
Consider the child's age, as younger children (especially <6 months) are at higher risk for severe disease and complications, as noted by Praxis Medical Insights 2

Ensure adequate hydration through oral fluids; IV fluids may be necessary if oral intake is inadequate or if there is significant vomiting, as recommended by Praxis Medical Insights 2
Manage fever with appropriate antipyretics (acetaminophen or ibuprofen) at age-appropriate dosages, according to Thorax 1
Monitor for signs of clinical deterioration including increased work of breathing, altered mental status, or persistent high fever, as advised by Praxis Medical Insights 2

Signs of respiratory distress including markedly raised respiratory rate, grunting, intercostal recession, or breathlessness with chest signs, as indicated by Thorax 1
Cyanosis or hypoxia requiring oxygen supplementation, according to Thorax 1
Severe dehydration or inability to maintain adequate oral intake, as recommended by Thorax 1
Altered level of consciousness or complicated seizures, as noted by Thorax 1
Signs of septicemia including extreme pallor, hypotension, or floppiness in infants, according to Thorax 1

For children with persistent fever who become clinically unstable, consider the possibility of secondary bacterial infection and broaden antimicrobial coverage accordingly, as recommended by Clinical Infectious Diseases 3
Children who initially present with viral exanthems occasionally develop secondary bacterial infections, particularly those with influenza or RSV requiring intensive care, according to Clinical Infectious Diseases 3
In children 3-5 years old with persistent symptoms, especially perihilar and bilateral pulmonary infiltrates with wheezing, consider testing for Mycoplasma or Chlamydia pneumoniae, as advised by Clinical Infectious Diseases 3 and Praxis Medical Insights 4
For children with persistent wheezing after a viral illness, consider short-acting beta-agonists and possibly a short course of inhaled corticosteroids, as recommended by Praxis Medical Insights 4

For suspected influenza with severe symptoms or in high-risk children, consider oseltamivir if within 48 hours of symptom onset, as recommended by Thorax 1
For suspected herpes simplex virus (HSV) or varicella-zoster virus (VZV) encephalitis, intravenous aciclovir should be started promptly, according to Journal of Infection 5

Provide clear guidance to parents about expected course of illness and when to seek medical attention, as advised by Praxis Medical Insights 4
Educate about signs of deterioration that warrant immediate medical evaluation, as recommended by Praxis Medical Insights 2

Overuse of antibiotics for viral exanthems without evidence of bacterial superinfection, as cautioned by Praxis Medical Insights 4
Failure to recognize signs of severe disease requiring hospital admission, as noted by Thorax 1
Inadequate monitoring for complications in high-risk children (young infants, immunocompromised), as advised by Praxis Medical Insights 2

The American Academy of Pediatrics recommends initiating oseltamivir immediately for children with moderate to severe symptoms consistent with influenza, particularly if presenting within 48 hours of symptom onset 6
The dosing for oseltamivir varies by body weight: 30 mg every 12 hours for children <15 kg, 45 mg every 12 hours for 15-23 kg, and 75 mg every 12 hours for >24 kg 7
IV acyclovir should be started promptly for suspected herpes simplex virus or varicella-zoster virus encephalitis 7
Infants under 1 year with suspected influenza may receive oseltamivir despite lack of FDA approval for this age group, as the benefits outweigh risks in severe disease 8

For children <12 years with suspected bacterial co-infection, co-amoxiclav is the drug of choice 7
For penicillin-allergic children, clarithromycin or cefuroxime should be used 7

Viral features include coryza, hoarseness, cough, diarrhea, conjunctivitis, and characteristic viral enanthems or exanthems, according to the American Heart Association, as reported in Circulation 9
Consider bacterial infection if there is extreme toxicity, focal findings, or rapid clinical deterioration, as suggested by the American Heart Association, in Circulation 9

For VZV encephalitis, the Infectious Diseases Society of America recommends intravenous aciclovir 10-15 mg/kg three times daily 10, 11, 12
VZV cerebellitis does not require antiviral treatment as it is self-limiting, according to the Infectious Diseases Society of America 10, 11, 12

For suspected HSV encephalitis, the Infectious Diseases Society of America recommends starting intravenous aciclovir immediately pending diagnostic confirmation 10, 12